Insider buying more than doubled last week with insiders buying $269.24 million of stock compared to $103.49 million in the week prior. Selling on the other hand decreased with insiders selling $1.33 billion of stock last week compared to $2.15 billion in the week prior.
Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week dropped to 4.93. In other words, insiders sold almost 5 times as much stock as they purchased.
The Sell/Buy ratio this week compares favorably with the prior week, when the ratio stood at 20.79. We are calculating an adjusted ratio by removing transactions by funds and companies and trying as best as possible only to retain information about insiders and 10% owners who are not funds or companies.
Insider Sell Buy Ratio March 18, 2016
Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.
Director Julian Baker acquired 800,000 shares of this drug discovery and development company, paying $63.98 per share for a total amount of $51.18 million. These shares were acquired indirectly through Baker Brothers Life Sciences Capital and other related entities.
Chief Executive Officer Michelle Dipp acquired 221,761 shares of this biotech company, paying $7.68 per share for a total amount of $1.7 million. These shares were purchased indirectly by Longwood Fund III LP.
Shares of this bedding products company were acquired by 2 insiders:
CEO & President Scott L. Thompson acquired 35,000 shares, paying $57.67 per share for a total amount of $2.02 million. Mr. Thompson increased his stake by 50.23% to 104,686 shares with this purchase.
EVP & President North America Richard W. Anderson acquired 17,430 shares, paying $57.32 per share for a total amount of $999,091. Mr. Anderson increased his stake by 50.18% to 52,162 shares with this purchase.
Shares of this biotech company were acquired by 3 insiders:
Director M. Kathleen Behrens acquired 75,000 shares, paying $16.28 per share for a total amount of $1.22 million. Ms. Behrens increased her stake by 201.80% to 112,166 shares with this purchase. 10,000 of these shares were purchased indirectly through a trust.
Director Richard Barry acquired 75,000 shares, paying $15.66 per share for a total amount of $1,174,185. Mr. Barry increased his stake by 2.37% to 3,241,014 shares with this purchase.
Director Ben Gil Price acquired 4,500 shares, paying $16.70 per share for a total amount of $75,144. Mr. Price increased his stake by 11.74% to 42,830 shares with this purchase.
Shares of this application software company were sold by 6 insiders:
Chairman David A. Duffield sold 350,000 shares for $70.29, generating $24.6 million from the sale. These shares were sold indirectly by The Dave & Cheryl Duffield Foundation.
Vice Chairman Michael A. Stankey sold 141,000 shares for $47.23, generating $6.66 million from the sale. 47,000 of these shares were sold as a result of exercising options immediately prior to the sale.
Co-President Philip W. Wilmington sold 34,275 shares for $70.43, generating $2.41 million from the sale.
Senior Vice President James Bozzini sold 12,500 shares for $71.02, generating $887,742 from the sale. These shares were sold as a result of exercising options immediately prior to the sale.
Co-President & CFO Mark S. Peek sold 8,817 shares for $72.31, generating $637,557 from the sale.
Director Michael M. McNamara sold 3,400 shares for $69.79, generating $237,286 from the sale. These shares were sold indirectly by Flextronics International USA, Inc. 2005 Senior Executive Deferred Compensation Plan.
Chief Operating Officer Sheryl Sandberg sold 109,000 shares for $111.46, generating $12.15 million from the sale. 52,504of these shares were sold as a result of exercising options immediately prior to the sale.
Chief Product Officer Christopher K. Cox sold 21,534 shares for $109.78, generating $2.36 million from the sale.
Chief Technology Officer Michael Todd Schroepfer sold 20,000 shares for $109.13, generating $2.18 million from the sale. These shares were sold as a result of exercising options immediately prior to the sale.
VP and General Counsel Colin Stretch sold 1,000 shares for $109.13, generating $109,130 from the sale.
CEO, Activision Publishing Eric Hirshberg sold 287,847 shares of this multimedia & graphics software company for $32.47, generating $9.35 million from the sale. 120,858 of these shares were sold as a result of exercising options immediately prior to the sale.
You can view the full list of sales from this Insider Sales page.
Disclaimer Clients of Signal Partners, LLC and I may have positions in any of these stocks at any time. Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.
Econintersect wants your comments,
data and opinion on the articles posted. You can also comment using Facebook directly using he comment block below.
Print this page or create a PDF file of this page
The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.
Take a look at what is going on inside of Econintersect.com